providing mental health &
substance abuse  services for
the people of Alameda County ...  

 
Click here to go to homepage!
 

Medicare Part D
Med. & Pharmacy User Guide
Guidelines for Practices
Medication Consent
MIA Medication Program
Antipsychotic Monitoring
Drug Information Updates
Continuing Med. Education
Newsletter

Print This Page


Click here to send us your feedback.

Last Updated:  01/29/2008

Copyright 2005
Alameda County Behavioral Health Care Services

 


Antipsychotic Medication Monitoring

 
As of 10/1/02, all patients on antipsychotics will be required to have the following parameters monitored as part of the Alameda County BHCS Practice Guidelines1:
 

Weight

Baseline, q visit x 9 months, then q 3 months

Glucose

Baseline, 6 months, then q year

Cholesterol/Triglycerides

Baseline, 6 months, then q year

Prolactin*

Baseline, 6 months, then q year

EKG**

Baseline & periodic**



* Risperidone and all conventional agents

** thioridazine, ziprasidone: Only in patients at risk for QTc polongation. Periodic monitoring dependent on changes in electrolyte status (hypokalemia or hypomagnesemia) as a result of diuretic therapy, diarrhea, etc.

These drugs are contraindicated in patients with a known history of QT prolongation (including congenital long QT syndrome), with recent acute myocardial infarction, with uncompensated heart failure or with a history /family history of syncope or sudden cardiac death. These agents should not be used with any drug that prolongs the QT interval, and should be discontinued in patients who are found to have a QTc interval over 500 milliseconds.

1 Marder, Essock, Kane, Lieberman, Schooler et al. The Mt. Sinai Conference on the Pharmacotherapy of Schizophrenia. Schizophrenia Bulletin V28:1, 2002. Pgs 5-16.